Published in Drugs on January 01, 2001
Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial. Eur J Heart Fail (2015) 1.25
Revascularization in patients with heart failure. CMAJ (2006) 1.18
Changes in heart failure medications in patients hospitalised and discharged. BMC Fam Pract (2006) 0.83
Practice patterns and outcomes in patients presenting to the emergency department with acute heart failure. Can J Cardiol (2009) 0.80
Prevalence of Heart Failure and Adherence to Process Indicators: Which Socio-Demographic Determinants are Involved? Int J Environ Res Public Health (2016) 0.77
Gaps in Medical and Device Therapy for Patients with Left Ventricular Systolic Dysfunction: The EchoGap Study. Open Cardiovasc Med J (2014) 0.75
Optimal dosing of angiotensin-converting enzyme inhibitors in patients with chronic heart failure: a cross-sectional study in Palestine. Ann Saudi Med (2009) 0.75
Core Measures for Congestive Heart Failure in a Tertiary Care Setting in Pakistan. Cureus (2016) 0.75
How to Improve Adherence to Life-saving Heart Failure Treatments with Potassium Binders. Card Fail Rev (2017) 0.75
Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med (2009) 12.63
Factors associated with mortality in feedlot cattle: the Bruce County Beef Cattle Project. Can J Comp Med (1980) 7.74
Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med (2000) 5.41
A Vibrio cholerae pathogenicity island associated with epidemic and pandemic strains. Proc Natl Acad Sci U S A (1998) 4.75
Use of pharmacogenetic and clinical factors to predict the therapeutic dose of warfarin. Clin Pharmacol Ther (2008) 4.54
Factors associated with mortality and treatment costs in feedlot calves: the Bruce County Beef Project, years 1978, 1979, 1980. Can J Comp Med (1982) 4.34
Factors associated with morbidity and mortality in feedlot calves: the Bruce County beef project, year two. Can J Comp Med (1981) 4.17
A bacteriophage encoding a pathogenicity island, a type-IV pilus and a phage receptor in cholera bacteria. Nature (1999) 3.89
Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med (1995) 3.77
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450-2C19 (CYP2C19) genotype and clopidogrel therapy. Clin Pharmacol Ther (2011) 3.53
What is the quality of drug therapy clinical practice guidelines in Canada? CMAJ (2001) 3.15
Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med (1995) 3.11
Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials (1999) 2.99
Comparative safety and effectiveness of sitagliptin in patients with type 2 diabetes: retrospective population based cohort study. BMJ (2013) 2.92
Clinical Pharmacogenetics Implementation Consortium guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 update. Clin Pharmacol Ther (2013) 2.73
In vitro activity of LY333328, an investigational glycopeptide antibiotic, against enterococci and staphylococci. Antimicrob Agents Chemother (1996) 2.63
Evidence-based medicine: a commentary on common criticisms. CMAJ (2000) 2.48
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation. Clin Pharmacol Ther (2013) 2.39
Visceral fat and race-dependent health risks in obese nondiabetic premenopausal women. Diabetes (1997) 2.26
The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1. Infect Immun (1995) 2.25
Practice-based research: lessons from community pharmacist participants. Pharmacotherapy (2001) 2.23
The pharmacogenetics research network: from SNP discovery to clinical drug response. Clin Pharmacol Ther (2007) 2.18
Vibrio cholerae O1 can assume a chlorine-resistant rugose survival form that is virulent for humans. J Infect Dis (1996) 2.17
Isolation of vancomycin-resistant enterococci from animal feed in USA. Lancet (1999) 2.12
Distribution of Vibrio vulnificus in the Chesapeake Bay. Appl Environ Microbiol (1996) 2.10
Eu oxidation state in fluorozirconate-based glass ceramics. J Appl Phys (2009) 2.06
Thiazolidinedione use and cancer incidence in type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab (2012) 2.06
A research-based guideline for appropriate use of transdermal fentanyl to treat chronic pain. Oncol Nurs Forum (1998) 2.03
Cloning and sequence of a region encoding a surface polysaccharide of Vibrio cholerae O139 and characterization of the insertion site in the chromosome of Vibrio cholerae O1. Mol Microbiol (1996) 2.01
Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac. Blood (1995) 1.99
Activation of the antioxidant response element in primary cortical neuronal cultures derived from transgenic reporter mice. J Neurochem (2002) 1.96
The McGurk effect in infants. Percept Psychophys (1997) 1.96
Thermal conductivity spectroscopy technique to measure phonon mean free paths. Phys Rev Lett (2011) 1.94
Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacodynamics. Clin Pharmacol Ther (1999) 1.93
Accuracy of an electromagnetic tracking device: a study of the optimal range and metal interference. J Biomech (1996) 1.89
Genetic and clinical predictors of warfarin dose requirements in African Americans. Clin Pharmacol Ther (2010) 1.88
Use of statins and the subsequent development of deep vein thrombosis. Arch Intern Med (2001) 1.82
Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure. Diabetologia (2010) 1.76
Clinical and immunologic characteristics of Vibrio cholerae O139 Bengal infection in North American volunteers. J Infect Dis (1995) 1.75
Relapsing invasive group B streptococcal infection in adults. Ann Intern Med (1995) 1.74
Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells. J Biol Chem (2001) 1.74
Development and testing of a nonradioactive DNA oligonucleotide probe that is specific for Vibrio cholerae cholera toxin. J Clin Microbiol (1992) 1.71
A novel process for updating recommendations for managing hypertension: rationale and methods. Can J Cardiol (2000) 1.71
Self-efficacy, psychosocial factors, and exercise behavior in traditional versus modified cardiac rehabilitation. J Cardiopulm Rehabil (2001) 1.67
Thoracoscopic neodymium: yttrium-aluminum garnet laser-assisted pulmonary resection. Ann Thorac Surg (1991) 1.67
Measuring quality of life in paediatric patients. Pharmacoeconomics (1999) 1.65
Cholera in Lima, Peru, correlates with prior isolation of Vibrio cholerae from the environment. Am J Epidemiol (1997) 1.65
Pharmacogenomics: the inherited basis for interindividual differences in drug response. Annu Rev Genomics Hum Genet (2001) 1.64
Cellular and humoral immune response of foals to vaccination with Corynebacterium equi. Can J Comp Med (1979) 1.64
The oxidation state of europium in halide glasses. J Phys Condens Matter (2011) 1.62
Cross-sectional validity of a modified Edmonton symptom assessment system in dialysis patients: a simple assessment of symptom burden. Kidney Int (2006) 1.56
A polymorphism in the NPPA gene associates with asthma. Clin Exp Allergy (2008) 1.52
Dandy-Walker malformation: etiologic heterogeneity and empiric recurrence risks. Clin Genet (1985) 1.52
Mutations in the extracellular protein secretion pathway genes (eps) interfere with rugose polysaccharide production in and motility of Vibrio cholerae. Infect Immun (2000) 1.50
Systemic hypertension in infants with severe bronchopulmonary dysplasia: associated clinical factors. Am J Perinatol (1993) 1.49
Capsular types of Vibrio vulnificus: an analysis of strains from clinical and environmental sources. J Infect Dis (1993) 1.47
Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials. Osteoporos Int (2014) 1.45
Dietary fat and serum lipids: an evaluation of the experimental data. Am J Clin Nutr (1993) 1.44
Chlorine and survival of "rugose" Vibrio cholerae. Lancet (1992) 1.43
Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. Clin Infect Dis (2007) 1.43
Strut fixation of an extensive flail chest. Ann Thorac Surg (1991) 1.43
Large-amplitude spin dynamics driven by a THz pulse in resonance with an electromagnon. Science (2014) 1.41
Translocation inhibitors define specificity of protein kinase C isoenzymes in pancreatic beta-cells. J Biol Chem (1997) 1.40
Use of beta-blockers for uncomplicated hypertension in the elderly: a cause for concern. J Hum Hypertens (2007) 1.40
Xeroderma pigmentosum, photosensitivity, and risk for skin cancer. J Invest Dermatol (1990) 1.40
Permeability of the mammalian blood-gas barrier and its components. Am J Physiol (1969) 1.39
Load relaxation and forces with activity in Hoffman external fixators: a clinical study in patients with Colles' fractures. J Hand Surg Am (1998) 1.38
Paramagnetic hyperfine splitting in the Eu Mössbauer spectra of CaF(2):Eu. Phys Rev B Condens Matter Mater Phys (2008) 1.38
Salmonella enterica serovar Typhimurium DT104 displays a rugose phenotype. Appl Environ Microbiol (2001) 1.37
beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension. Clin Pharmacol Ther (2008) 1.37
Phylogeny of Vibrio cholerae based on recA sequence. Infect Immun (2000) 1.37
Program participation, exercise adherence, cardiovascular outcomes, and program cost of traditional versus modified cardiac rehabilitation. Am J Cardiol (2000) 1.35
Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity: characterization of gene duplication events. Clin Pharmacol Ther (2007) 1.35
Filtration and reflection coefficients of the rabbit blood-brain barrier. Am J Physiol (1966) 1.33
Insulin use and increased risk of mortality in type 2 diabetes: a cohort study. Diabetes Obes Metab (2009) 1.32
A model for capillary exchange. Am J Physiol (1966) 1.32
Invasive group B streptococcal disease in Maryland nursing home residents. J Infect Dis (2001) 1.31
Emergence of serotype V group B streptococcal infection among infants and adults. J Infect Dis (1995) 1.31
Effect of exercise on longevity, body weight, locomotor performance, and passive-avoidance memory of C57BL/6J mice. Neurobiol Aging (1985) 1.30
An outbreak of Salmonella enteritidis infection at a fast-food restaurant: implications for foodhandler-associated transmission. J Infect Dis (1991) 1.29
Equilibrium and kinetic properties of the Evans blue-albumin system. Am J Physiol (1969) 1.28
Selective functionalization of amino acids in water: a synthetic method via catalytic C-H bond activation. J Am Chem Soc (2001) 1.27
The pathology of experimental Corynebacterium equi infection in foals following intrabronchial challenge. Vet Pathol (1983) 1.26
Insulin use and cancer risk in patients with type 2 diabetes: a systematic review and meta-analysis of observational studies. Diabetes Metab (2012) 1.25
Nrf2-dependent activation of the antioxidant responsive element by tert-butylhydroquinone is independent of oxidative stress in IMR-32 human neuroblastoma cells. Biochem Biophys Res Commun (2001) 1.24
Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity. Clin Diagn Lab Immunol (1997) 1.23
The effect of muscle-sparing versus standard posterolateral thoracotomy on pulmonary function, muscle strength, and postoperative pain. J Thorac Cardiovasc Surg (1991) 1.22
Predictors of medication noncompliance in a sample of older adults. Clin Ther (1994) 1.22
Inhibition of 7,12-dimethylbenz(a)anthracene- and N-nitrosomethylurea-induced rat mammary cancer by dietary flavonol quercetin. Cancer Res (1988) 1.22
Quality of life in patients treated with hemodialysis or peritoneal dialysis: what are the important determinants? Clin Nephrol (2003) 1.21
Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial. Osteoporos Int (2009) 1.20